Alloplex Biotherapeutics
type: Person
type: Organization

logo
type: ImageObject
caption: Alloplex Biotherapeutics
language: en-US
width: 589
height: 506

Alloplex Biotherapeutics
type: WebSite
publisher: Alloplex Biotherapeutics
language: en-US
potential action: SearchAction
  target: https://alloplexbio.com/
  query-input: required name=search_term_string

Alloplex-Bio.jpg
type: ImageObject
width: 1200
height: 630
caption: Alloplex Biotherapeutics
language: en-US

Novel Immunotherapy for Cancer | Alloplex Biotherapeutics
type: WebPage
date published: 2021-10-20T02:10:34-04:00
date modified: 2026-07-26T21:23:19-04:00
about: Alloplex Biotherapeutics
is part of: Alloplex Biotherapeutics
language: en-US

Niroshan Shrestha
type: Person

https://secure.gravatar.com/avatar/c58e63416e6bda27c9a70128f68357e78fe0652c256150525691386c57d1afba
type: ImageObject
caption: Niroshan Shrestha
language: en-US

Novel Immunotherapy for Cancer | Alloplex Biotherapeutics
type: Article
keywords: immune system,cellular therapy,biotherapeutics,cellular therapeutic
date published: 2021-10-20T02:10:34-04:00
date modified: 2026-07-26T21:23:19-04:00
author: Niroshan Shrestha
publisher: Alloplex Biotherapeutics
description: Alloplex presents a patented cell-retraining platform that, by utilizing synergy between key immune pathways, reveals a previously unappreciated dimension of human immunology.
is part of: Novel Immunotherapy for Cancer | Alloplex Biotherapeutics
language: en-US
main entity of page: Novel Immunotherapy for Cancer | Alloplex Biotherapeutics